Health
Moderna Announces New Drug Application Submitted to Import and Distribute Moderna’s COVID-19 Vaccine Candidate in Japan – Business Wire
Moderna announces New Drug Application submitted to import and distribute Moderna’s COVID-19 vaccine candidate in Japan.
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Takeda Pharmaceutical Co., Ltd (NYSE: TAK) submitted a New Drug Application to the Government of Japans Ministry of Health, Labour and Welfare (MHLW) to import and distribute Modernas vaccine candidate against COVID-19 (mRNA-1273 or TAK-919) in Japan. TAK-919 is Takedas development code for Modernas COVID-19 vaccine candidate.
Submitting…
-
Noosa News17 hours agoSee inside the hidden suburbs where Queensland investors really live
-
Noosa News17 hours agoBusiness expo sparks inspiration and connection
-
Noosa News16 hours agoThe best new books released in August, from Toni Jordan, Rhett Davis and more
-
Business16 hours agoWhy it’s time to buy Domino’s, Flight Centre, and WiseTech shares